We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Customized Isotopes Hold Promise for Advances in Science

By Biotechdaily staff writers
Posted on 05 Jun 2008
A promising future in nuclear physics is in the design of isotopes--the ability scientists have to construct specific rare isotopes to solve scientific problems and create avenues to new technologies, according to investigators.

"We have developed a remarkable capability over the last 10 or so years that allows us to build a specific isotope to use in research,” said Dr. More...
Bradley Sherrill, a professor of physics and associate director for research at the National Superconducting Cyclotron Laboratory (NSCL) at Michigan State University (MSU; East Lansing, USA). "It is a new tool that promises to allow whole new directions in research to move forward. There are tremendous advances that are possible.”

Dr. Sherrill described some of the possibilities, and what it will take to get there, in an article in the May 9, 2008, issue of Science magazine. In that article, he reported that nanotechnology is getting a lot of attention for the amazing possibilities of building objects with individual atoms and molecules. Developments in basic nuclear science already have given way to technologies such as PET scans--medical procedures that use special isotopes to target specific types of tumors.

Isotopes are the different versions of an element. Their nuclei have different numbers of neutrons, and thus give them different characteristics. Rare isotopes do not always exist in nature--they must be enticed out with high-energy collisions created by special machines, like those in MSU's Coupled Cyclotron facility. As technology advances, newer equipment is needed.

The next step for the U.S. nuclear science community will be the Facility for Rare Isotope Beams, a world-leading facility for the study of nuclear structure and nuclear astrophysics, expected to be built by the U.S. Department of Energy sometime in the next decade.

According to Dr. Sherrill, this type of basic science--science to evaluate the core nature of the elements of life--has a lot of potential. He offers up positron emission tomography (PET) scans--as an example of the payoff associated with pushing the bounds of accelerator science to assess new specific isotopes. To create PET scans, scientists first had to create an isotope with a specific radioactivity that decayed quickly enough and safely enough to inject in the body.

"The rare-isotope research supported by National Science Foundation at the NSCL enables us to push forward our understanding of nuclei at the frontiers of stability, with direct connections to the processes that produce the elements in our world and that underlie the life cycle of stars,” said Bradley Keister, a program officer in NSF Physics Division. "Applications to societal areas including medicine and security have traditionally gone hand in hand with these ever-advancing capabilities.”

In the Science article, Dr. Sherrill stated that aggressively pursuing rare isotope research is necessary. "These are isotopes that are not easy to produce. That's the frontier we're working on, Dr. Sherrill wrote in his article. "A wider range of available isotopes should benefit the fields of biomedicine [by producing an expanded portfolio of radioisotopes], international security [by providing the technical underpinning to nuclear forensics specialists], and nuclear energy [by leading to better understanding of the sort of nuclear reactions that will power cleaner, next-generation reactors].”


Related Links:
National Superconducting Cyclotron Laboratory at Michigan State University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.